icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm

Pharmstandard posts FY 2010 net profit of 7.163 billion roubles

Pharmstandard posts FY 2010 net profit of 7.163 billion roubles
Russian pharmaceutical maker, Pharmstandard, has posted a FY 2010 net profit of 7.163 billion roubles under IFRS.

­The net result was up 4.5% year on year from the 6.852 billion rouble profit posted for FY 2009, with FY 2010 EBITDA up 0.5% year on year to 9.685 billion roubles, as revenues climbed 23.2% year on year to 29.686 billion roubles.

The company noted that sales of its own drugs increased 9.9% and sales of 3rd party drugs jumped 60%, offsetting an 8.5% fall in sales of medical equipment.

Podcasts